Cargando…
Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
We recently reported that six 1,4-dihydropyridine derivatives out of 57 screened effectively over-came vincristine (VCR)-resistance in VCR-resistant (P388/VCR) leukaemia-bearing mice when the dihydropyridines and VCR were administered intraperitoneally (i.p.). Furthermore, among the six dihydropyrid...
Autores principales: | Kiue, A., Sano, T., Naito, A., Okumura, M., Kohno, K., Kuwano, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977534/ https://www.ncbi.nlm.nih.gov/pubmed/1892749 |
Ejemplares similares
-
Reversal by Two Dihydropyridine Compounds of Resistance to Multiple Anticancer Agents in Mouse P388 Leukemia in vivo and in vitro
por: Kiue, Akira, et al.
Publicado: (1990) -
Tin-based Antitumour Drugs
por: Gielen, Marcel
Publicado: (1994) -
Antitumour Drug-Radiation Interactions
por: Carmichael, J.
Publicado: (1992) -
Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines
por: Mahbub, A A, et al.
Publicado: (2015) -
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
por: Rossin, Raffaella, et al.
Publicado: (2018)